Speaker illustration

Miss Ana Belen Salido Medina

Instituto de Investigacion Sanitaria Valdecilla (IDIVAL), Santander (Spain)

Activation of bone morphogenetic protein type 1A receptors (BMPR1A) by THR184 halts the progression of the left ventricular remodelling under pressure overload

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Drugs, Drug Targets

Session: Moderated poster 4 AWARD


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb